packageIbandronicAcid

ibandronic acid

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Ibandronic acid is a bisphosphonate used to treat postmenopausal osteoporosis and other bone diseases, and to prevent bone complications from breast cancer. It is an approved medicine with several products still authorised in the European Union, though some EU marketing authorisations have lapsed or been withdrawn.

Summary written by glm-5.3-flash from Wikidata Q166825 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:ibandronic acid
ATC codes:M05BA06
DrugBank:DB00710
PubChem CID:60852
Wikidata:Q166825
formula:C9H23NO7P2
molar mass:319.231 g/mol (PubChem CID 60852)
logP:-4.1 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown